The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
Open accessAbstract
Cancer is a multistage process resulting in an uncontrolled and abrupt division of cells and is one of the leading causes of mortality. The cases reported and the predictions for the near future are unthinkable. Food and Drug Administration data showed that 40% of the approved molecules are natural compounds or inspired by them, from which, 74% are used in anticancer therapy. In fact, natural products are viewed as more biologically friendly, that is less toxic to normal cells. In this review, the most recent and successful cases of secondary metabolites, including alkaloid, diterpene, triterpene and polyphenolic type compounds, with great anticancer potential are discussed. Focusing on the ones that are in clinical trial development or already used in anticancer therapy, therefore successful cases such as paclitaxel and homoharringtonine (in clinical use), curcumin and ingenol mebutate (in clinical trials) will be addressed. Each compound’s natural source, the most important steps in their discovery, their therapeutic targets, as well as the main structural modifications that can improve anticancer properties will be discussed in order to show the role of plants as a source of effective and safe anticancer drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Ekor, M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00177 · Cited by 3,919
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9432-8 · Cited by 2,110
Stability of curcumin in buffer solutions and characterization of its degradation products
Wang, Y.-J., Pan, M.-H., Cheng, A.-L., Lin, L.-I., Ho, Y.-S., Hsieh, C.-Y., & Lin, J.-K. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(96)02024-9 · Cited by 1,705
How Taxol/paclitaxel kills cancer cells
Weaver, B. A. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0916 · Cited by 1,547
Curcumin, an active component of turmeric (Curcuma longa), and its effects on health
Kocaadam, B., & Şanlier, N. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1077195 · Cited by 1,207
Natural product discovery: past, present, and future
Katz, L., & Baltz, R. H. (2016) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-015-1723-5 · Cited by 1,144
Nicolaou, K. C., Yang, Z., Liu, J. J., Ueno, H., Nantermet, P. G., Guy, R. K., Claiborne, C. F., Renaud, J., Couladouros, E. A., Paulvannan, K., et al. (1994) · Nature · doi:10.1038/367630a0 · Cited by 1,096
Pisha, E., Chai, H., Lee, I.-S., Chagwedera, T. E., Farnsworth, N. R., Cordell, G. A., Beecher, C. W. W., Fong, H. H. S., Kinghorn, A. D., Brown, D. M., et al. (1995) · Nature Medicine · doi:10.1038/nm1095-1046 · Cited by 886
Natural products: An evolving role in future drug discovery
Mishra, B. B., & Tiwari, V. K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.057 · Cited by 860
Natural product and natural product derived drugs in clinical trials
Butler, M. S., Robertson, A. A. B., & Cooper, M. A. (2014) · Nat. Prod. Rep. · doi:10.1039/c4np00064a · Cited by 602
Oral bioavailability of curcumin: problems and advancements
Liu, W., Zhai, Y., Heng, X., Che, F. Y., Chen, W., Sun, D., & Zhai, G. (2016) · Journal of Drug Targeting · doi:10.3109/1061186x.2016.1157883 · Cited by 566
Betulinic Acid and Its Derivatives: A Review on their Biological Properties
Yogeeswari, P., & Sriram, D. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053202214 · Cited by 553
Plant-derived compounds in clinical trials
Saklani, A., & Kutty, S. K. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.010 · Cited by 477
Use of traditional medicine in middle-income countries: a WHO-SAGE study
Oyebode, O., Kandala, N.-B., Chilton, P. J., & Lilford, R. J. (2016) · Health Policy and Planning · doi:10.1093/heapol/czw022 · Cited by 428
Paclitaxel: What has been done and the challenges remain ahead
Bernabeu, E., Cagel, M., Lagomarsino, E., Moretton, M., & Chiappetta, D. A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.016 · Cited by 413
Lead Phytochemicals for Anticancer Drug Development
Singh, S., Sharma, B., Kanwar, S. S., & Kumar, A. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.01667 · Cited by 411
Natural products for human health: an historical overview of the drug discovery approaches
Bernardini, S., Tiezzi, A., Laghezza Masci, V., & Ovidi, E. (2018) · Natural Product Research · doi:10.1080/14786419.2017.1356838 · Cited by 355
Biological and therapeutic activities, and anticancer properties of curcumin
PERRONE, D., ARDITO, F., GIANNATEMPO, G., DIOGUARDI, M., TROIANO, G., LO RUSSO, L., DE LILLO, A., LAINO, L., & LO MUZIO, L. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2749 · Cited by 348
Curcumin mediates anticancer effects by modulating multiple cell signaling pathways
Kunnumakkara, A. B., Bordoloi, D., Harsha, C., Banik, K., Gupta, S. C., & Aggarwal, B. B. (2017) · Clinical Science · doi:10.1042/cs20160935 · Cited by 332
The modification of natural products for medical use
Guo, Z. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.06.003 · Cited by 328
Plant Secondary Metabolites: Biosynthesis, Classification, Function and Pharmacological Properties
Justin, Kabera, Edmond, Semana, Ally, Mussa, Xin, X., & He, H. (2014) · Journal of Pharmacy and Pharmacology · Cited by 295
Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis
Gali-Muhtasib, H., Hmadi, R., Kareh, M., Tohme, R., & Darwiche, N. (2015) · Apoptosis · doi:10.1007/s10495-015-1169-2 · Cited by 293
Indole Alkaloids from Catharanthus roseus: Bioproduction and Their Effect on Human Health
Almagro, L., Fernández-Pérez, F., & Pedreño, M. (2015) · Molecules · doi:10.3390/molecules20022973 · Cited by 291
The structural modification of natural products for novel drug discovery
Yao, H., Liu, J., Xu, S., Zhu, Z., & Xu, J. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1272757 · Cited by 275
Barbuti, A., & Chen, Z.-S. (2015) · Cancers · doi:10.3390/cancers7040897 · Cited by 269
Cancer risk and diet in India.
Sinha, R. R., Anderson, D. E., McDonald, S. S., & Greenwald, P. (2003) · PubMed · Cited by 266
Traditional use and safety of herbal medicines1
Moreira, D. D. L., Teixeira, S. S., Monteiro, M. H. D., De-Oliveira, A. C. A. X., & Paumgartten, F. J. R. (2014) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2014.03.006 · Cited by 266
Docetaxel and Paclitaxel in the Treatment of Breast Cancer: A Review of Clinical Experience
Crown, J., O'Leary, M., & Ooi, W.-S. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_2-24 · Cited by 249
Characterization of the Interaction of Ingenol 3-Angelate with Protein Kinase C
Kedei, N., Lundberg, D. J., Toth, A., Welburn, P., Garfield, S. H., & Blumberg, P. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3403 · Cited by 209
Paclitaxel: biosynthesis, production and future prospects
Howat, S., Park, B., Oh, I. S., Jin, Y.-W., Lee, E.-K., & Loake, G. J. (2014) · New Biotechnology · doi:10.1016/j.nbt.2014.02.010 · Cited by 208
An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis
Adeloye, D., David, R. A., Aderemi, A. V., Iseolorunkanmi, A., Oyedokun, A., Iweala, E. E. J., Omoregbe, N., & Ayo, C. K. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153496 · Cited by 200
Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates
Xiao, Z., Morris‐Natschke, S. L., & Lee, K. (2016) · Medicinal Research Reviews · doi:10.1002/med.21377 · Cited by 195
A systematic review on ethnomedicines of anti-cancer plants
Tariq, A., Sadia, S., Pan, K., Ullah, I., Mussarat, S., Sun, F., Abiodun, O. O., Batbaatar, A., Li, Z., Song, D., et al. (2017) · Phytotherapy Research · doi:10.1002/ptr.5751 · Cited by 189
Emerging Cytotoxic Alkaloids in the Battle against Cancer: Overview of Molecular Mechanisms
Habli, Z., Toumieh, G., Fatfat, M., Rahal, O., & Gali-Muhtasib, H. (2017) · Molecules · doi:10.3390/molecules22020250 · Cited by 178
Novel delivery system for natural products: Nano-curcumin formulations.
Rahimi, H. R., Nedaeinia, R., Shamloo, A. S., Nikdoust, S., & Oskuee, R. K. (2016) · Europe PMC (PubMed Central) · Cited by 176
Vincristine-induced peripheral neuropathy in children with cancer: A systematic review
van de Velde, M. E., Kaspers, G. L., Abbink, F. C. H., Wilhelm, A. J., Ket, J. C. F., & van den Berg, M. H. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.04.004 · Cited by 174
Enioutina, E. Y., Salis, E. R., Job, K. M., Gubarev, M. I., Krepkova, L. V., & Sherwin, C. M. T. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1268917 · Cited by 162
Rosen, R. H., Gupta, A. K., & Tyring, S. K. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.12.038 · Cited by 161
Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
Rivera, E., & Cianfrocca, M. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2607-5 · Cited by 159
Ali‐Seyed, M., Jantan, I., Vijayaraghavan, K., & Bukhari, S. N. A. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12682 · Cited by 158
Bernabeu, E., González, L., Cagel, M., Gergic, E. P., Moretton, M. A., & Chiappetta, D. A. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.01.003 · Cited by 157
Anticancer Properties of Traditional Chinese Medicine
Yan, Z., Lai, Z., & Lin, J. (2017) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207320666170116141818 · Cited by 153
Kantarjian, H. M., O'Brien, S. M., & Cortes, J. E. (2013) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2013.03.017 · Cited by 146
Xu, X., Wang, L., Xu, H.-Q., Huang, X., Qian, Y.-D., & Xiang, J. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.4.2591 · Cited by 144
Paclitaxel Formulations: Challenges and Novel Delivery Options
Nehate, C., Jain, S., Saneja, A., Khare, V. R., Alam, N., Dubey, R., & Gupta, P. N. (2014) · Current Drug Delivery · doi:10.2174/1567201811666140609154949 · Cited by 140
Fu, Z., Chen, X., Guan, S., Yan, Y., Lin, H., & Hua, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.3625 · Cited by 132
Unraveling the Anticancer Effect of Curcumin and Resveratrol
Pavan, A. R., Silva, G., Jornada, D. H., Chiba, D. E., Fernandes, G., Chin, C. M., & dos Santos, J. L. (2016) · Nutrients · doi:10.3390/nu8110628 · Cited by 132
A New Semisynthesis of Paclitaxel from Baccatin III
Baloglu, E., & Kingston, D. G. I. (1999) · Journal of Natural Products · doi:10.1021/np990040k · Cited by 128
Kumar, G., Mittal, S., Sak, K., & Tuli, H. S. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.022 · Cited by 126
Omacetaxine: a protein translation inhibitor for treatment of chronic myelogenous leukemia
Gandhi, V., Plunkett, W., & Cortes, J. E. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1283 · Cited by 118
New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds
Redondo-Blanco, S., Fernández, J., Gutiérrez-del-Río, I., Villar, C. J., & Lombó, F. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00109 · Cited by 113
Natural products against cancer angiogenesis
Bairi, K. E., El-Kenawy, A. E.-M., Rahman, H. S., Guaâdaoui, A., & Najda, A. (2016) · Tumor Biology · doi:10.1007/s13277-016-5364-8 · Cited by 105
Evolutionary Perspectives on the Role of Plant Secondary Metabolites
Delgoda, R., & Murray, J. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802104-0.00007-x · Cited by 105
North African Medicinal Plants Traditionally Used in Cancer Therapy
Alves-Silva, J. M., Romane, A., Efferth, T., & Salgueiro, L. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00383 · Cited by 104
Cucurmin, anticancer, & antitumor perspectives: A comprehensive review
Imran, M., Ullah, A., Saeed, F., Nadeem, M., Arshad, M. U., & Suleria, H. A. R. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1252711 · Cited by 101
Gao, Y., Jia, Z., Kong, X., Li, Q., Chang, D. Z., Wei, D., Le, X., Suyun, H., Huang, S., Wang, L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2016 · Cited by 100
Advances in exploring alternative Taxol sources
Liu, W.-C., Gong, T., & Zhu, P. (2016) · RSC Advances · doi:10.1039/c6ra06640b · Cited by 97
Yang, C., Ma, X., Wang, Z., Zeng, X., Hu, Z., Ye, Z., & Shen, G. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s126964 · Cited by 97
Effect of Betulinic Acid on Anticancer Drug‐Resistant Colon Cancer Cells
Jung, G., Kim, K., Choi, C.-H., Lee, T., Han, S. I., Han, H., & Lim, S. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00115.x · Cited by 90
Curcumin and cancer stem cells: curcumin has asymmetrical effects on cancer and normal stem cells.
Sordillo, P. P., & Helson, L. (2015) · PubMed · Cited by 88
Preclinical profile of cabazitaxel
Vrignaud, P., Benning, V., Beys, E., Gupta, S., Sémiond, D., & Bouchard, H. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s64940 · Cited by 88
Homoharringtonine (omacetaxine mepesuccinate) as an adjunct forFLT3-ITD acute myeloid leukemia
Lam, S. S. Y., Ho, E. S. K., He, A. B.-L., Wong, W.-W., Cher, C. Y., Ng, N. K. L., Man, C., Gill, H., Cheung, A. M. S., Ip, H., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf3735 · Cited by 85
Betulinic Acid as a Potent and Complex Antitumor Phytochemical: A Minireview
Gheorgheosu, D., Duicu, O., Dehelean, C. A., Şoica, C., & Muntean, D. M. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520614666140223192148 · Cited by 84
Douer, D. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0391 · Cited by 83
nab-Paclitaxel as a potential partner with checkpoint inhibitors in solid tumors
Soliman, H. H. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s122974 · Cited by 82
Allan, E. K., Holyoake, T. L., Craig, A. R., & Jørgensen, H. G. (2011) · Leukemia · doi:10.1038/leu.2011.55 · Cited by 81
Vincristine: Can its therapeutic index be enhanced?
Moore, A. S., & Pinkerton, C. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22161 · Cited by 80
Shankar, E., Zhang, A., Franco, D., & Gupta, S. (2017) · Molecules · doi:10.3390/molecules22020264 · Cited by 76
Ogbourne, S. M., & Parsons, P. G. (2014) · Fitoterapia · doi:10.1016/j.fitote.2014.07.002 · Cited by 75
Multiple molecular targets in breast cancer therapy by betulinic acid
Luo, R., Fang, D., Chu, P., Wu, H., Zhang, Z., & Tang, Z. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.018 · Cited by 73
Betulinic acid induces a novel cell death pathway that depends on cardiolipin modification
Potze, L., Franco, S. D., Grandela, C., Pras‐Raves, M. L., Picavet, D. I., van Veen, H. A., van LENTHE, H., Mullauer, F. B., van der Wel, N. N., Luyf, A. C. M., et al. (2015) · Oncogene · doi:10.1038/onc.2015.102 · Cited by 72
Ramya, P., Angapelly, S., Guntuku, L., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.12.043 · Cited by 71
Micellar paclitaxel improves severe psoriasis in a prospective phase II pilot study
Ehrlich, A., Booher, S. L., Becerra, Y., et al. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.09.018 · Cited by 68
Serova, M., Ghoul, A., Benhadji, K. A., Faivre, S. J., Tourneau, C. L., Cvitkovic, E., Lokiec, F. M., Lord, J. M., Ogbourne, S. M., Calvo, F. M., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2060 · Cited by 65
Are PEGylated liposomes better than conventional liposomes? A special case for vincristine
Wang, X., Song, Y., Su, Y., Tian, Q., Li, B., Quan, J., & Deng, Y. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1027015 · Cited by 64
Schwertheim, S., Wein, F., Lennartz, K., Worm, K., Schmid, K. W., & Sheu‐Grabellus, S. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2380-z · Cited by 62
Current approach to the treatment of chronic myeloid leukaemia
Pašić, I., & Lipton, J. H. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.01.005 · Cited by 60
Jade, D., Ramamoorthi, G., Kannan, J., Kotteeswaran, V., & Sivalingam, N. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.034 · Cited by 57
Sertel, S., Fu, Y., Zu, Y., et al. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.026 · Cited by 54
Taxol from Corylus avellana: paving the way for a new source of this anti-cancer drug
Gallego, A., Malik, S., Yousefzadi, M., Makhzoum, A. B., Trémouillaux‐Guiller, J., & Bonfill, M. (2017) · Plant Cell Tissue and Organ Culture (PCTOC) · doi:10.1007/s11240-016-1164-5 · Cited by 54
Cortes, J. E., Kantarjian, H. M., Réa, D., Wetzler, M., Lipton, J. H., Akard, L. P., Khoury, H. J., Michallet, M., Guerci‐Bresler, A., Chuah, C. T. H., et al. (2015) · Cancer · doi:10.1002/cncr.29240 · Cited by 53
In vivo and in vitro effects of curcumin on head and neck carcinoma: a systematic review
Borges, G. Á., Rêgo, D. F., Assad, D. X., Coletta, R. D., Canto, G. D. L., & Guerra, E. N. S. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12455 · Cited by 53
Synthesis and antiproliferative studies of curcumin pyrazole derivatives
Puneeth, H. R., Ananda, H., Kumar, K. S. S., Rangappa, K. S., & Chandrashekariah, S. A. (2016) · Medicinal Chemistry Research · doi:10.1007/s00044-016-1628-5 · Cited by 49
Xu, Y., Li, J., Li, Q., Feng, Y., & Pan, F. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.034 · Cited by 47
Benhadji, K. A., Serova, M., Ghoul, A., Cvitkovic, E., Tourneau, C. L., Ogbourne, S. M., Lokiec, F. M., Calvo, F. M., Hammel, P. R., Faivre, S. J., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604642 · Cited by 46
Ma, L., Wang, B., Long, Y., & Li, H. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0512-0 · Cited by 45
Holonec, L., Ranga, F., CRAINIC, D., et al. (2012) · Notulae Botanicae Horti Agrobotanici Cluj-Napoca · doi:10.15835/nbha4027967 · Cited by 40
Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation
de Morrée, E. S., van Soest, R. J., Aghai, A., de Ridder, C., de Bruijn, P., Moghaddam-Helmantel, I. M. G., Burger, H., Mathijssen, R. H. J., Wiemer, E. A. C., de Wit, R., et al. (2016) · The Prostate · doi:10.1002/pros.23182 · Cited by 39
A comprehensive approach to ascertain the binding mode of curcumin with DNA
Haris, P., Varughese, M., Aparna, P., Dileep, K. V., & Sudarsanakumar, C. (2016) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2016.11.049 · Cited by 38
Negative-Pressure Cavitation Extraction of Four Main Vinca Alkaloids from Catharanthus roseus Leaves
Mu, F., Yang, L., Wang, W., Luo, M., Fu, Y., Guo, X., & Zu, Y. (2012) · Molecules · doi:10.3390/molecules17088742 · Cited by 37
Recent advances in design, synthesis and bioactivity of paclitaxel-mimics
Wen, G., Qu, X., Wang, D., Chen, X.-X., Tian, X., Gao, F., & Zhou, X. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.02.010 · Cited by 37
Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions
Raj, R., Mongia, P. R., Sahu, S. K., & Ram, A. (2016) · Current Drug Targets · doi:10.2174/1389450116666150722141607 · Cited by 36
Recent progress on curcumin-based therapeutics: a patent review (2012-2016). Part I: Curcumin
Martino, R. M. C. D., Luppi, B., Bisi, A., Gobbi, S., Rampa, A., Abruzzo, A., & Belluti, F. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1276566 · Cited by 36
Chen, J., Mu, Q., Li, X., Yin, X., Yu, M., Jin, J., Li, C., Zhou, Y., Zhou, J., Suo, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16956 · Cited by 36
Heiblig, M., Sobh, M. A. K., & Nicolini, F. E. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.05.007 · Cited by 29
The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia
Li, X., Yin, X., Wang, H., Huang, J., Yu, M., Ma, Z., Li, C., Zhou, Y., Xiao, Y., Huang, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14463 · Cited by 24
Effect of NF-κB inhibition on chemoresistance in biliary–pancreatic cancer
Uwagawa, T., & Yanaga, K. K. (2015) · Surgery Today · doi:10.1007/s00595-015-1129-z · Cited by 23
A safety evaluation of omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia
Damlaj, M., Lipton, J. H., & Assouline, S. E. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1207760 · Cited by 16
Ricci, F., Guffanti, F., Damia, G. L. M., & Broggini, M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0662-3 · Cited by 15
Search for Anti-angiogenic Substances from Natural Sources
Kotoku, N., Arai, M., & Kobayashi, M. (2016) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c15-00744 · Cited by 14
Dadgar, S., Ramjan, Z., & Floriano, W. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301829h · Cited by 12
Goyal, S. D., Oak, E., Luo, J. R., Cashen, A. F., Carson, K. R., Fehniger, T. A., DiPersio, J. F., Bartlett, N. L., & Wagner‐Johnston, N. D. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1330954 · Cited by 7
Cited by
Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy
Dehelean, C. A., Marcovici, I., Soica, C., Mioc, M., Coricovac, D., Iurciuc, S., Cretu, O. M., & Pinzaru, I. (2021) · Molecules · doi:10.3390/molecules26041109 · Cited by 502
Nile, S. H., Thiruvengadam, M., Wang, Y., Samynathan, R., Shariati, M. A., Rebezov, M., Nile, A., Sun, M., Venkidasamy, B., Xiao, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01423-8 · Cited by 457
Elshafie, H. S., Camele, I., & Mohamed, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043266 · Cited by 439
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
Kashyap, D., Tuli, H. S., Yerer, M. B., Sharma, A., Sak, K., Srivastava, S., Pandey, A., Garg, V. K., Sethi, G., & Bishayee, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.014 · Cited by 390
The Akt pathway in oncology therapy and beyond (Review)
Nitulescu, G., Van De Venter, M., Nitulescu, G., Ungurianu, A., Juzenas, P., Peng, Q., Olaru, O., Grădinaru, D., Tsatsakis, A., Tsoukalas, D., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4597 · Cited by 328
Metadata
- Authors
- Seca, A., & Pinto, D.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-01-16
- Volume
- 19
- Issue
- 1
- Pages
- 263
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2789001259
- Cited by
- 686
- References
- 105
- FWCI
- 22.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.